Drug Trial Radar · NCT07441876
Study to Evaluate the Efficacy and Safety of BMN 333 Versus Vosoritide in Children With Achondroplasia
Last checked: Nov 19, 2026Latest source record: Oct 22, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
160
Planned (sponsor's estimate)
Start
Apr 20, 2026
Primary completion
Jun 2029
Study completion Sep 2029
Sponsor
- Lead sponsor
- BioMarin PharmaceuticalBioMarin (BMRN)
- Sponsor type
- Industry
- First posted
- Mar 2, 2026
Design
- Study type
- Interventional
- Phase
- Phase 2 / Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Single (outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 2 years, up to 17 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a multicenter, multinational, randomized, active-controlled, operationally seamless Phase 2/3 study of BMN 333 in treatment-naïve pediatric participants with achondroplasia (ACH). The study consists of a Phase 2 part and a Phase 3 part.
Conditions
- Achondroplasia
Interventions
BMN 333Drug
Administration: Weekly subcutaneous injection
Vosoritide Injection [Voxzogo]Drug
Administration: Daily subcutaneous injection
Primary outcomes
What the sponsor says the trial is designed to measure.
- Phase 2: Predicted Annualized Growth Velocity (AGV) at Week 52 (based on AGV at Weeks 26, 39, and 52 [available cumulative data]Time frame: 52 weeks
- Phase 3: Annualized Growth Velocity (AGV) at Week 52Time frame: 52 weeks
Locations
28 sites in 9 countries. Site status is shown where the registry gives one.
UCSF Benioff Children's Hospital Oakland
Oakland, California · Recruiting
Nemours Children's Health
Wilmington, Delaware · Not yet recruiting
Ann & Robert H. Lurie Children's Hospital of Chicago
Chicago, Illinois · Recruiting
Johns Hopkins Medicine
Baltimore, Maryland · Recruiting
Cincinnati Children's Hospital Medical Center
Cincinnati, Ohio · Recruiting
Children's Hospital of Philadelphia
Philadelphia, Pennsylvania · Recruiting
Texas Children's Hospital
Dallas, Texas · Recruiting
Texas Children Hospital, Baylor College of Medicine
Houston, Texas · Recruiting
Consano Clinical Research, LLC
San Antonio, Texas · Recruiting
Murdoch Children's Research Institute
Parkville, Victoria, Australia · Recruiting
McGill University Health Centre
Québec, Monteral, Canada · Recruiting
Universite de Montreal - Centre Hospitalier Universitaire Sainte-Justine
Montreal, Quebec, Canada · Recruiting
Irccs Ospedale Gaslini Di Genova
Genova, Italy · Not yet recruiting
Fondazione IRCCS Ca Grande Ospedale Maggiore
Milan, Italy · Not yet recruiting
Hokkaido University Hospital
Hokkaido, Japan · Recruiting
Osaka City General Hospital
Osaka, Japan · Recruiting
National Center for Child Health and Development
Tokyo, Japan · Recruiting
Uniwersytecki Szpital Kliniczny im. J. Mikulicza-Radeckiego we Wroclawiu Klinika Pediatrii i Chorob Infekcyjnych
Wroclaw, Poland · Recruiting
Institutul National de Endocrinologie C.I.Parhon
Bucharest, Romania · Recruiting
Craiova Emergency Clinical County
Craiova, Romania · Recruiting
Seoul National University Hospital
Seoul, South Korea · Recruiting
Pusan National University Yangsan Hospital
Yangsan, South Korea · Recruiting
University Hospitals Bristol NHS Foundation Trust - Bristol Royal Hospital for Children
Bristol, United Kingdom · Recruiting
Queen Elizabeth University Hospital
Glasgow, United Kingdom · Recruiting
Alder Hey Childrens NHS Foundation Trust
Liverpool, United Kingdom · Recruiting
Great Ormond Street Hospital
London, United Kingdom · Recruiting
St Thomas Hospital
London, United Kingdom · Recruiting
University NHS Foundation Trust NIHR Wellcome Trust Clinical Research Facility
Manchester, United Kingdom · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.